Erie, PA (HQ)
Pioneering Precision Ophthalmology Trials
Actively advancing a robust clinical pipeline evaluating the safety and clinical utility of our diagnostic platforms across ophthalmic conditions.
| Trial | Condition | N | Status | Location |
|---|---|---|---|---|
| OPTICA | Dry AMD (Geographic Atrophy) | 50 | Active | USA (Erie, PA) |
| PRIDE | Diabetic Retinopathy + DME | 180 | Active | Brazil |
| BOLT | Neovascular AMD (nAMD) | 90 | Planned | Philippines (Manila) |
| NOOR | Diabetic Eye Disease (DR + DME) | TBD | Planned | Saudi Arabia (KKESH) |
| ROVER | Uveitis / Intraocular Inflammation | TBD | Planned | India |
PRIDE Study Site
Manila — BOLT
KKESH — NOOR
ROVER Site